Funded Health Care Startups in London
Across these 50 London health care rounds, the largest disclosed amount is Perci Health’s $4M on 2025-06-11.
Across these 50 London health care rounds, the largest disclosed amount is Perci Health’s $4M on 2025-06-11. That figure stays within the same general “single-digit millions” band as other large disclosed entries (e.g., Semble’s $15M on 2024-10-23 and Hexarad’s $14M on 2024-08-15), but the list contains multiple much smaller disclosed rounds clustered around $1M–$2M (for example, MintNeuro’s $1M on 2024-11-12 and Univa Health’s $1M on 2024-10-07), with several $10K–$440K datapoints (e.g., CorpusAnalytiX at $10K on 2025-02-11; Keyron at $30K on 2024-09-06).
Timing is uneven: the most recent entries run from 2025-10-02 (Good Life Sorted, $30K) back to 2023-05-25 (Dr Newmans Clinic, $2M). Stage/label reporting is also mixed: 19 of 50 rows use “Series Unknown,” and 7 of 50 are “undisclosed,” making disclosed-size comparisons most reliable where amounts are present (e.g., 2025’s Equity Crowdfunding to Series A range from $30K at Good Life Sorted on 2025-10-02 to $400K at Little Journey on 2025-07-17).
Most recent rounds
50 shownRelated listings
Frequently asked
What’s the largest disclosed round in this London health care list, and does it dwarf the rest?
The largest disclosed amount is $4M for Perci Health (2025-06-11). The next-largest disclosed amounts visible around it include $2M–$15M entries elsewhere in the window (e.g., Hexarad $14M on 2024-08-15; Semble $15M on 2024-10-23), so Perci Health’s $4M is not an isolated extreme compared with the biggest disclosed deals in the same dataset.
How much of the recent activity is concentrated near the top of the date range?
The newest round shown is Good Life Sorted on 2025-10-02 ($30K), and multiple entries land in a tight 2025 window: Voda (2025-06-18, $870K), Perci Health (2025-06-11, $4M), ReactWise (2025-03-17, $2M), and Habitual (2025-04-10, $1M). By contrast, the oldest row is Dr Newmans Clinic on 2023-05-25 ($2M), indicating a multi-year spread rather than a single cluster at the far end.
Are “Series Unknown” and “undisclosed” amounts common enough to limit stage-based conclusions?
Yes: 19 of 50 rows are labeled “Series Unknown,” and 7 of 50 are “undisclosed.” That means any stage-by-stage sizing takeaways should rely on the remaining rows with explicit stages and disclosed amounts (e.g., Little Journey Series A on 2025-07-17 at $400K; Semble Series B on 2024-10-23 at $15M; Univa Health Pre-Seed on 2024-10-07 at $1M).
Do disclosed round sizes cluster into a particular band, or are they widely dispersed?
Disclosed amounts show clustering at lower ticket sizes: multiple rounds sit around $1M–$2M (MintNeuro $1M on 2024-11-12; KLIQ $2M on 2024-02-27; Lumeon $2M on 2024-06-05). There are also small-ticket outliers within the disclosed set—CorpusAnalytiX at $10K on 2025-02-11 and GG Care at $60K on 2023-06-07—while several high-end disclosed rounds extend to the mid-teens (e.g., Semble $15M and Hexarad $14M).
Which entries look like outliers worth deeper diligence based on disclosed size?
Within the disclosed amounts, the clear large-end standouts are Semble ($15M on 2024-10-23) and Hexarad ($14M on 2024-08-15), both materially above the $1M–$2M concentration seen across entries like MintNeuro ($1M on 2024-11-12) and Univa Health ($1M on 2024-10-07). On the low end, CorpusAnalytiX at $10K (2025-02-11) and Keyron at $30K (2024-09-06) sit far below the rest of the disclosed range.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.